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1. Introduction 
To create new in vitro culture models for extrapolating the cell response in vivo, Takezawa et 
al. have attempted to devise culture substrata of anchorage-dependent cells (Takezawa et al., 
1990; Takezawa et al., 1992; Takezawa & Yoshizato, 1997; Takezawa et al., 2000; Takezawa et 
al., 2002; Takezawa, 2003; Takezawa et al., 2004; Takezawa et al., 2007a; Takezawa et al., 
2007b; Takezawa et al., 2008a; Takezawa et al., 2008b; Takezawa et al., 2010).  One model is a 
culture system utilizing substrata made of tissue/organ sections for histopathology 
(TOSHI), which was found to conserve both tissue components and microarchitecture in an 
in vivo environment (Takezawa et al., 2002; Takezawa, 2003). 
Meanwhile, it is reported that mouse embryonic stem (ES) cells injected into the tail veins of 
carbon tetrachloride (CCl4) liver-injured mouse were differentiated into hepatocyte-like cells 
in the host liver (Yamamoto et al., 2003).  Therefore, we investigated whether the ES cells 
could also be differentiated into hepatocyte-like cells when they were cultured on the 
TOSHI-substrata prepared from livers in various stages after CCl4 administration into mice.  
Consequently, it was found that the substrata derived from regenerating livers enhanced 
cell attachment, supported growth as clusters, and induced differentiation into cells 
expressing albumin, although the substrata from injured livers did not.  In particular, the 
cells cultured on the most proliferative regenerating liver-derived substratum reconstructed 
the hepatic cord-like structures with bile canaliculus-like aspects in which some binucleated 
cells were involved, secreted albumin, and expressed cytochrome P450IA1 activity within a 
few days (Takeuchi et al., 2008; Takezawa et al., 2008; Takezawa et al., 2008b). 
These data suggest two advantages based on the behavior of ES cells in a culture system 
utilizing TOSHI-substrata; one is that TOSHI-substratum derived from regenerating livers 
with high proliferative potential efficiently induced the differentiation of ES cells toward 
hepatic lineage and another is that ES cells functioned as a sensor recognizing liver toxicity 
in TOSHI-substratum derived from injured livers after CCl4 administration into mice.  
Therefore, it is considered that the former would be available for the novel approach of drug 
discovery to find bioactive factors and the latter provide a new alternative method of animal 
experiments in toxicology to support drug development. 
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In this chapter, I propose a novel strategy for drug discovery and development by analyzing 
the behavior of ES cells cultured on TOSHI-substrata.  Section 2 describes the basics and 
advantages of a cell culture system utilizing TOSHI-substrata.  Section 3 presents behavior 
of mouse ES cells cultured on TOSHI-substrata derived from livers in various stages after 
CCl4 administration into mice.  Section 4 proposes a novel concept for drug discovery and 
development utilizing the behavior of ES cells cultured on TOSHI-substrata.  Section 5 
presents a discussion and summarizes the paper. 
2. The basics and advantages of a cell culture system utilizing TOSHI-
substrata 
In this section I describe the basic outline of a cell culture system utilizing TOSHI-substrata 
and the advantages of investigating cell behavior on TOSHI-substrata.  A novel idea for 
diagnosing characteristics of undefined cells and tissues will be introduced as applied 
concepts for “cellomics” and “histomics”, respectively. 
2.1 The basic outline of a cell culture system utilizing TOSHI-substrata 
A lot of cell culture substrata that control multicellular behaviors have been developed from 
natural or synthetic or their hybrid materials and are currently utilized for reconstructing 
organoids as cellular scaffold(s) in tissue/organ engineering (Takezawa et al., 2000).  
However, no one has succeeded in producing a culture substratum reflecting the complex 
architecture of various cellular microenvironments in tissues in vivo.  On the other hand, 
thin tissue/organ sections commonly prepared on a glass slide for histopathology retain 
many in vivo biochemical attributes related not only to structure but also function. We 
hypothesized that such tissue/organ sections might serve as novel cell culture substrata that 
would reflect conditions in vivo. 
In the beginning study, such novel culture substrata made of tissue/organ sections for 
histopathology (TOSHI-substrata) were prepared from a frozen bovine placenta embedded 
in an OCT compound, and subsequently four different types of cells were cultured on the 
substrata.  As the results, the labyrinth region of the substratum induced unique cell 
behaviors to form multicellular spheroids of BeWo cells (human choriocarcinoma cell line), a 
capillary network-like structure of CPAE cells (bovine pulmonary artery endothelial cell 
line), and a neuronal network-like structure of PC-12 cells (rat pheochromocytoma cell line).  
The substratum provided a microenvironment that maintained the viability of PC-12 cells 
under serum-free conditions.  Also, we succeeded in preparing a multicellular mass of 
NHDFs (normal human dermal fibroblasts) with acellularized section-derived components 
(Takezawa et al., 2002). 
The typical experimental procedure for a cell culture system utilizing TOSHI-substrata was 
shown in Figure 1. 
2.2 The advantages of investigating cell behavior on TOSHI-substrata 
TOSHI-substrata can be prepared various tissues and every cell line can be cultured on the 
TOSHI-substrata, and consequently we can analyze the behavior of each cell line induced by 
each TOSHI-substratum. Therefore, we consider that it will be available to construct the 
database cumulated diverse interactions between culture cells and tissues/organs of the 
substrata.  As the first step, we recently prepared TOSHI-substrata from normal rat mature 
organs (cerebrum, thymus, heart, liver, kidney and testis) in a frozen state and cultured two 
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Fig. 1. Schematic procedure for preparing TOSHI (tissue/organ sections for histopathology) 
-substrata and culturing cells on it.  Reproduced and partially-modified with permission of 
the publisher (Takezawa et al., 2008a). 
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different cell lines (RIN5F cells of rat insulinoma and HepG2 cells of human hepatoma) to 
compare their behaviors on the substrata. As the results, RIN5F cells showed high 
attachability onto the TOSHI-substrata derived from heart and kidney, standard growth on 
the substrata from heart, kidney, and liver, and high level of insulin secretion on the 
substratum from thymus.  Whereas HepG2 cells showed low attachability onto the TOSHI-
substrata derived from liver, and kidney and not only standard growth but also standard 
level of albumin secretion on the substrata from cerebrum, thymus, heart, liver, kidney and 
testis.  Also, the time-course profiles for cell growth and secretion level of insulin or albumin 
on each TOSHI-substratum were successfully converted into a three-dimensional graph 
chart, i.e. a mathematical model.  In conclusion, it was demonstrated that the mathematical 
profile describing cell behavior was specific for the combination of a cell line and a 
tissue/organ of the substrata   (Yanagihara et al., 2007).  These findings suggest that we can 
provide novel research concept for cellomics and histomics (Fig. 2).  Here, cellomics and 
histomics facilitate comprehensive analyses for various cell lines using one tissue/organ-
derived TOSHI-substratum and for various tissue/organ-derived TOSHI-substrata using 
one cell line, respectively.  In future, the database construction for cellomics and histomics 
would lead a new system for diagnosing characteristic-unknown cell line or a characteristic-
unknown TOSHI-substratum by feedback of the cell behavior profile obtained from the 
combinations of “a characteristic-unknown cell line and characteristic-known TOSHI-
substrata” or “characteristic-known cell lines and a characteristic-unknown TOSHI-
substratum” to the database. 
Further, applied researches such as induction of cell differentiation, serum-free culture, 
exploration and/or production of bioactive molecules, estimation of gene function, and 
reconstruction of tissues will be achieved by designing an appropriate combination of a cell 
line and a TOSHI-substratum. 
3. Behavior of mouse ES cells cultured on TOSHI-substrata derived from 
livers in various stages after CCl4 administration into mice 
In this section I mainly describe our previous study to differentiate mouse ES cells towards 
hepatic lineage utilizing TOSHI-substrata derived from regenerating livers after CCl4 
administration into mice (Takeuchi et al., 2008), then briefly introduce a new strategy for 
predicting the toxicity of chemicals. 
3.1 Background for the study to differentiate mouse ES cells towards hepatic lineage 
Embryonic stem (ES) cells differentiate into tissues of all the three germ layers, and the effort 
is to restrict or direct their development to specific cell type or lineage.  A number of studies 
have attempted to produce hepatocytes from ES cells and have successfully induced hepatic 
development in vitro  (Ishi et al., 2005; Lavon & Benvenisty, 2005; Novik et al., 2006; Teratani 
et al., 2005; Zhou et al., 2007).  However, all these studies have used culture systems 
supplemented by a temporal series of growth factors similar to those known to control 
embryonic liver development and therefore limited success, e.g. low efficacy of hepatic 
differentiation or it takes long period.  Meanwhile, mouse ES cells injected into the tail vein 
of carbon tetrachloride (CCl4) liver-injured mouse were differentiated into hepatocyte-like 
cells in the host liver  (Yamamoto et al., 2003).  Here, we aimed to investigate whether the ES 
cells could also be differentiated into hepatocyte-like cells when they were cultured on the 
TOSHI-substrata prepared from livers in various stages after CCl4-administration into mice. 
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Fig. 2. Novel research concept for cellomics and histomics.  Reproduced and partially-
modified with permission of the publisher (Takezawa et al., 2008a). 
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3.2 Preparation of TOSHI-substrata reflecting liver failure and regeneration after CCl4-
administration into mice 
Male mice (129SV) were purchased from CLEA. Light liver injury was caused by 
intraperitoneally injecting 100 μl of olive oil containing 10 μl of CCl4 into 8 week-old mice 
weighing between 18 and 23 g to induce liver regeneration. As a control, 100 μl of olive oil 
alone was intraperitoneally injected into other mice. The blood sera and livers of the mice at 
12, 24 and 48 h, 4, 7 and 15 days after CCl4-administration and at 24 h after olive oil-
administration were subjected to the measurement of aspartate aminotransferase (AST) 
leakage level and the preparation of TOSHI-substrata, respectively. Livers were excised 
immediately after sacrificing the mice, embedded in an OCT compound and rapidly frozen 
with liquid nitrogen. The frozen livers were cut into sections with a thickness of 5 μm.  The 
liver-derived sections were spread onto a glass slide and air-dried to yield TOSHI-substrata.  
All animal experiments were performed in accordance with the guidelines of the 
Experimental Animal Committee at the National Institute of Agrobiological Sciences. 
 
Fig. 3. Analytical protocol of liver failure and regeneration after CCl4-administration into 
mice. 
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To investigate the time-course changes of liver failure and regeneration, the AST leakage 
level in blood sera was measured by utilizing an assay kit for AST (Wako). Also, TOSHI-
substrata without culturing cells were subjected to standard hematoxylin and eosin (HE) 
staining and immuno-histological staining for proliferating cell nuclear antigen (PCNA), 
and observed by a light microscope.  Subsequently, the PCNA-positive cell number in a unit 
area of 1.31 mm2 on each substratum was counted from three independent 
microphotographs (Fig. 3). 
As a result, the serum AST level of liver-injured mice increased more than three times from 
12 to 48 h after CCl4-administration, then gradually decreased and finally recovered on day 
15 (Table 1). Meanwhile, immuno-histological observations of liver-derived TOSHI-
substrata revealed that the PCNA-positive cell number increased in mice from 24 h to 7 days 
after CCl4-administration and that the peak representing about 27-fold of the control mice 
was seen in mice on day 4 (Table 1). Also, this progression process of liver failure and 
regeneration was clearly confirmed by observation of the TOSHI-substrata stained with HE 
(Takeuchi et al., 2008). 
3.3 Culture of mouse ES cells on TOSHI-substrata reflecting liver failure and 
regeneration after CCl4-administration into mice 
Mouse ES cells, J1 cell clones of 129SV male origin, and pALB-EGFP/ES cells [a stable mouse 
ES J1 cell line carrying a plasmid vector of pALB-EGFP which drives expression of albumin 
promoter-induced green fluorescent protein (GFP)] were sub-cultured on feeder fibroblasts 
according to the previous method (Teratani et al., 2005; Yamamoto et al., 2003).  TOSHI-
substrata reflecting liver failure and regeneration after CCl4-administration, a control TOSHI-
substratum prepared from a liver of the mice at 24 h after olive oil-administration, and a 
TOSHI-free glass slide substratum were subjected to the optimization for cell culture.  Each 
substratum was inserted into a well of 4-well culture plates (Greiner), and immersed twice in 
phosphate buffered saline (PBS) containing 200 units/ml penicillin and 200 μg/ml 
streptomycin for 10 min and once in the culture medium for 5 min before use. 
To investigate cell attachability, growth, morphology and differentiation into the cells 
expressing albumin, the suspension of pALB-EGFP/ES cells prepared in a culture medium 
[Dulbecco's Modified Eagle Medium with 4.5 g/l glucose (DMEM) containing 20% heat-
inactivated fetal bovine serum (FBS), 1,000 units/ml leukemia inhibitory factor (LIF) (ESGRO; 
Chemicon), 100 μM 2-mercaptoethanol (2-ME), 0.1 mM non-essential amino acids, 30 μM 
Adenosine, 30 μM Guanosine, 30 μM Cytidine, 30 μM Uridine, 10 μM Thymidine, 100 
units/ml penicillin, 100 μg/ml streptomycin and 250 ng/ml Amphotericin B] was seeded on 
each substratum at an initial cell density of 1.0 x 105 cells/cm2 (Fig. 4).  The cells were cultured 
at 37oC in a humidified atmosphere of 5% CO2 in air and the culture media were once changed 
to basal media of a DMEM alone at 2 h in culture.  The morphology and GFP expression of 
pALB-EGFP/ES cells cultured on each substratum were observed over time by a phase-
contrast microscope and a fluorescent one under the same visual field, respectively.  For 
analyzing the attachability, growth and differentiation of pALB-EGFP/ES cells, the area of the 
regions occupied by cells in a unit area of 1.18 mm2 on each substratum at 2, 8, 16, 24 and 48 h 
in culture and that of their GFP-positive parts at 24 h were measured by applying NIH image 
software to computer images converted from three independent microphotographs, and 
consequently the ratio of the area occupied by cells and the appearance ratio of GFP-positive 
cells among the cells on each substratum were calculated, respectively.  Similarly, each area of 
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ten cell colonies on the CCl4-4d substratum and the appearance ratio of GFP-positive cells in 
each colony were calculated at 2, 8, 16, 24, 48, 96 and 168 h in culture. 
As a result, the initial cell attachment onto the control TOSHI-substratum prepared from 
livers at 24 h after olive oil-administration into mice (cont.-substratum) was 1.7-hold higher 
than that onto the glass slide-substratum (glass-substratum). As compared to the cont.-
substratum, the TOSHI-substratum prepared from livers at 12 h after CCl4-administration 
into mice (CCl4-12h substratum) suppressed the attachment of ES cells whereas the CCl4-4d 
and CCl4-7d substrata promoted it (Table 1). The population of pALB-EGFP/ES cells 
cultured in the basal media gradually decreased on any substratum except for the CCl4-4d 
substratum as the culture period increased. Most colonies on the CCl4-4d substratum 
expanded their size until 16 or 24 h in culture, and subsequently reduced the size due to 
spontaneous detachment of the colony cells from the substratum. About 10 % of the colonies 
on the CCl4-4d substratum enlarged its size more than 4-fold at 24 h, suggesting the colony 
cells divided about 2 times within 24 h. Furthermore, GFP-positive cells indicating the 
albumin expression appeared in some colonies formed on the CCl4-4d substratum at 16 h in 
culture and were still observed at 168 h.  To the contrary, pALB-EGFP/ES cells cultured on 
the glass-, cont.-, CCl4-12h, CCl4-24h substrata did not express GFP. The extent of GFP 
positive cells on the CCl4-48h, CCl4-4d, CCl4-7d, CCl4-15d substrata was about 46, 70, 24, 
26% of the cells at 24 h in culture, respectively (Table 2). Morphological observation revealed  
 
 
Table 1. Ratio changes of AST leakage level in sera, PCNA-positive cells and cell 
attachability in TOSHI-substrata at 12h, 24h, 48h, 4d, 7d and 15d after CCl4-administration 
in comparison to the control serum and TOSHI-substratum at 24 h after olive oil-
administration. The initial cell attachability onto each substratum were examined after 
culturing the cells in a culture medium mainly supplemented with fetal bovine serum, 
leukemia inhibitory factor, and 2-mercaptoethanol for 2 h. 
 
Table 2. The ratio of GFP positive cells in the cells cultured on the indicated substrata for 
24h. 
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Fig. 4. Experimental protocol of investigating the behavior of pALB-EGFP/ES cells cultured 
on TOSHI-substrata reflecting liver failure and regeneration after CCl4-administration. 
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that pALB-EGFP/ES cells cultured for 24 h on the glass-, cont.-, CCl4-12h, CCl4-24h 
substrata were remarkably reduced in number due to spontaneous detachment from each 
substratum, and that the retained cells relatively small and round in shape were 
individually scattered on each substratum and entirely negative for GFP expression. In 
contrast, those on the CCl4-48h, CCl4-4d, CCl4-7d, CCl4-15d substrata mostly participated in 
forming clusters in which the cells tended to express GFP and relatively large colonies were 
observed on the sinusoidal capillary region of the CCl4-4d and CCl4-7d substrata. In 
particular, the colonies on the CCl4-4d substratum showed reconstruction of hepatic cord-
like structures with bile canaliculus-like aspects (Harada et al., 2003) between the cells in 
polygonal shape and most of the colony cells expressed GFP. 
Further, to investigate any changes in hepatic morphology and function ES cells were 
seeded and cultured on the CCl4-4d substratum (Fig. 5). The culture medium mainly 
containing FBS, LIF and 2-ME was changed to a basal medium without the supplements at 2 
h to estimate the effect of the substratum on cell growth and differentiation after inducing 
cell adherence under the presence of serum.  ES cells cultured on the CCl4-4d substratum for 
24 h were stained with HE and observed by a light microscope.  The albumin secretion level 
into a culture medium was measured by utilizing an assay kit for mouse albumin 
(Shibayagi). The cytochrome P450IA1 activity was analyzed by adding ethoxyresorufin (ER) 
into the culture media at a final concentration of 10 mM, incubating for 60 min and 
measuring the resorufin production level (Sakai et al., 2002). 
 
 
Fig. 5. Experimental protocol of investigating the hepatic differentiation of ES cells cultured 
on TOSHI-substratum derived from regenerating livers at 4 days after CCl4 administration. 
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Consequently, binucleated cells in a polygonal shape appeared in the colonies cultured for 
24 h. Albumin secretion into a culture medium and the cytochrome P450IA1 activity 
metabolizing ER to the dealkylated resorufin were confirmed at 48 and 62 h in culture, 
respectively (Fig. 6).  Also, the CCl4-4d substratum alone released albumin and reached to 
the plateau level of 0.1 ng/ml until 24 h, however it did not possess the cytochrome P450IA1 
activity. 
 
Fig. 6. Hepatic differentiation of ES cells cultured on TOSHI-substratum derived from 
regenerating livers at 4 days after CCl4 administration. 
In this study, we demonstrated that the CCl4-4d substratum had a high potential to 
efficiently differentiate ES cells into hepatocyte-like clonies with some functional and 
morphological characteristics of mature parenchymal hepatocytes within a few days.  Thus, 
we succeeded in directly differentiating ES cells into hepatic cells without the use of any 
soluble growth factor and also the process of embryoid body formation although either was 
essential for conventional methods (Ishi et al., 2005; Lavon & Benvenisty, 2005; Novik et al., 
2006; Teratani et al., 2005; Zhou et al., 2007).  Also, each TOSHI-substratum prepared from 
livers in various stages after CCl4-administration into mice had different activities for 
inducing behavior of ES cells.  It is quite interesting that the CCl4-15d substratum was 
different from the cont.-substratum and retained the induction activity of differentiation 
although the mice on 15 days after CCl4-administration showed the normal level of both 
serum AST and liver PCNA-positive cell index, suggesting that liver regeneration-related 
factor(s) was deposited in the CCl4-15d substratum. Such ES cell behavior-regulating 
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factor(s) that was sustained on each TOSHI-substratum prepared from CCl4-administrated 
mouse livers is unclear at present.  To investigate the molecular mechanism inducing the 
different profile of ES cell behavior on each TOSHI-substratum, we are planning to treat the 
TOSHI-substratum with antibody or enzyme in biological approach, fixation agent or 
detergent in chemical approach, and/or heat or ultra violet irradiation in physical approach. 
3.4 A new strategy for predicting the toxicity of chemicals 
In the above experiment, the serum AST level indicating liver injury and the number of 
PCNA-positive cells indicating liver regeneration increased more than twice of the control 
from 12 h to 4 d with the peak (about 3.4-fold of the control) at 24 h and from 24 h to 7 d 
with the peak (about 27-fold of the control) at 4 d after CCl4-administration, respectively 
(Table 1).  On the other hand, the initial cell attachability of pALB-EGFP/ES cells to TOSHI-
substrata prepared from livers after CCl4 administration into mice represented -31% on the 
CCl4-12h and -11% on CCl4-24h substrata whereas +20% on the CCl4-4d and CCl4-7d 
substrata in comparison to the control TOSHI-substratum (Table 1). Also, the CCl4-48h, 
CCl4-4d, CCl4-7d and CCl4-15d substrata showed the induction activity to differentiate the 
pALB-EGFP/ES cells to the cells expressing GFP (Table 2). These findings suggest that time-
dependent toxic changes of CCl4 in liver in vivo can be estimated by the cell behaviors of 
pALB-EGFP/ES cells cultured on the TOSHI-substrata prepared from livers after CCl4 
administration into mice. 
I think that an organ-specific toxicity level after drug administration or chemical exposure 
can be defined as not only injury intensity of differentiated cells composing the organ but 
also regeneration activity of stem cells in the organ. Here, the above study demonstrated 
that the injury intensity and regeneration activity was predicted by the initial cell 
attachability and differentiation efficiency of ES cells cultured on the TOSHI-substrata 
derived from livers after administrating chemical into mice, respectively. Therefore, I 
propose as a new strategy for predicting the toxicity of drugs or chemicals in human by 
utilizing the time-course cell behavior of human stem cells cultured on the TOSHI-substrata 
derived from various organs after exposing some chemical into experimental animals.  The 
human stem cells include ES cells, iPS (induced pluripotent stem) cells and somatic stem 
cells (e.g. mesenchymal stem cells), (Fig. 7). 
4. A novel concept for drug discovery and development utilizing the behavior 
of ES cells cultured on TOSHI-substrata 
In this section I describe the recent progress of ES cell-based assay systems for drug 
discovery and development, then introduce advantages of the ES cell-based assay system 
utilizing TOSHI-substrata in drug discovery and development. 
4.1 Recent progress of ES cell-based assay systems for drug discovery and 
development 
ES cells are pluripotent stem cells possessing the capacity for self-renewal of proliferating 
indefinitely and multilineage differentiation. Therefore, ES cells generally function as a 
ready source of large quantities of partially differentiated progenitors or terminally 
differentiated specialized cells, which serve as cell-based assay systems (Sartipy et al., 2007).  
Somatic stem cell marker prominin-1/CD133, a plasma membrane marker is expressed in  
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Fig. 7. A novel strategy for extrapolating the toxicity in vivo utilizing TOSHI–substrata. 
ES-derived progenitors but not in differentiated cells (Kania et al., 2005). ES-derived somatic 
stem cells such as hematopoietic and neural stem cells and also ES-derived differentiated 
mature cells such as cardiomyocytes and hepatocytes have been utilized for drug screening 
and toxicity assessment as ES cell-based assay systems in vitro (Kettenhofen & Bohlen, 2008; 
Kuegler et al., 2010; Ma et al., 2008; Sartipy et al., 2007).  Recently, various high-throughput 
cellular microarray platforms have been developed in a viewpoint for applying ES cells to 
drug discovery and development (Derda et al., 2007; Flaim et al., 2008).  Consequently, it has 
been realized that the ability to track stem cell fate decisions and to quantify specific stem 
cell markers on microarray platforms has the potential to increase our understanding of the 
cellular mechanisms involved. Here, signals emanating from the stem cell 
microenvironment, or niche, are crucial in regulating stem cell fate. These signals include 
physical cues (e.g. matrix elasticity, cell–cell and cell–ECM interactions) and soluble factors 
(e.g. growth factors and small molecules) (Fernandes et al., 2009). 
4.2 Advantages of the ES cell-based assay system utilizing TOSHI-substrata in drug 
discovery and development 
The greatest merit of utilizing TOSHI-substrata is to provide niches reflecting various 
conditions in tissue(s)/organ(s) in vivo towards ES cells, resulting in the generation of assay 
systems for estimating not only biological activity but also the drug efficacy and chemical 
toxicity remained in the TOSHI-substrata by analyzing the behavior of the ES cells.  
Therefore, it is available to propose new research strategies for exploring bioactive 
molecule(s) involved in the TOSHI-substrata and/or for extrapolating pharmacological and 
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toxicological effect(s) of chemicals in human. As the exploration research, bioactive 
molecules such as ligand, growth factor, growth inhibitor and differentiation-inducing 
factor would be isolated from specific regions in the TOSHI-substrata where ES cells 
revealed behaviors such as adhesion, proliferation, apoptosis and differentiation, 
respectively.  Also, as the pharmacological and toxicological research, the TOSHI-substrata 
would provide two applications.  One is means for efficiently differentiating human ES cells 
to sufficient amount of mature differentiated cells (e.g. hepatocytes) by utilizing the TOSHI-
substrata derived from a regenerating tissue/organ.  The other is a novel extrapolation 
system of the drug efficacy and/or toxicity by investigating the behavior of human ES cells 
cultured on the TOSHI-substrata derived from every tissue/organ of experimental animals 
after administrating drugs and/or exposing chemicals, respectively (Fig. 7). 
5. Conclusions 
I presented the basics and advantages of a cell culture system utilizing TOSHI (tissue/organ 
sections for histopathology)–substrata, and introduced a new platform for orienting 
differentiation of mouse ES cells towards hepatic lineage utilizing TOSHI-substrata derived 
from regenerating liver after CCl4-administration into mice. Also, I proposed a new strategy 
for applying the ES cell-based assay system utilizing TOSHI-substrata to the researches in 
drug discovery and development.  I hope that such a new strategy could contribute not only 
to expand the utility of ES cells but also to generate a high-throughput assay system 
utilizing TOSHI-substrata as a tissue/organ microarray useful for extrapolating drug 
efficacy and chemical toxicity in human body. 
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